We are incredibly proud to see our spinoff, Entoptica, making waves on the international stage!
At the recent Asian Finance Forum, Dr. Mukhit Kulmaganbetov, CEVR Senior Research Fellow and Co-founder of Entoptica, stepped into the spotlight to pitch their revolutionary macular health diagnostic tool: the SLOPE Device (Structured Light Observation and Perception Evaluation Device ).
By showcasing this breakthrough to a global room of visionary investors, Entoptica is highlighting the sheer strength of Hong Kong’s MedTech ecosystem.
Why SLOPE is a breakthrough in eye health:

Quantum-Powered: Leverages structured light to detect early stage of macular issues with unprecedented precision.

Proactive Protection: Shifts the clinical focus from "managing" vision loss to "preventing" it through early intervention.